Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study

Amra Jujić, Naeimeh Atabaki-Pasdar, Peter M. Nilsson, Peter Almgren, Liisa Hakaste, Tiinamaija Tuomi, Lisa M. Berglund, Paul W. Franks, Jens J. Holst, Rashmi B. Prasad, Signe S. Torekov, Susana Ravassa, Javier Díez, Margaretha Persson, Olle Melander, Maria F. Gomez, Leif Groop, Emma Ahlqvist, Martin Magnusson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalDiabetologia
Volume63
Issue number5
Pages (from-to)1043-1054
Number of pages12
ISSN1432-0428
DOIs
Publication statusPublished - May 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 General medicine, internal medicine and other clinical medicine
  • Cardiovascular
  • Cardiovascular events
  • Coronary artery disease
  • GIP
  • GLP-1
  • Glucagon-like peptide 1
  • Glucose-dependent insulinotropic peptide
  • Mendelian randomisation
  • Mortality
  • MENDELIAN RANDOMIZATION ANALYSES
  • POLYPEPTIDE
  • OSTEOPONTIN
  • LIRAGLUTIDE
  • PREVALENCE
  • DIAGNOSIS
  • OUTCOMES
  • LOCI

Cite this